Navigation Links
Graphic warning labels on cigarette packages reduce smoking rates

The U.S. would have several million fewer smokers if graphic warning labels similar to those introduced in Canada nearly a decade ago were required on cigarette packs, according to researchers at the University of Illinois at Chicago and the University of Waterloo.

The Canadian labels led to a 2.9 to 4.7 percentage point drop in smoking rates -- which would mean 5.3 to 8.6 million fewer smokers in the U.S. if the same result were obtained. The findings are published online in the journal Tobacco Control.

The researchers used statistical methods to compare smoking rates in the U.S. and Canada for a nine-year period before and after the graphic warning labels were introduced in Canada. The price of cigarettes were factored into the analyses.

The study found the "regulatory impact analysis" used by the U.S. Food and Drug Administration to gauge the effectiveness of Canada's graphic warning labels to be inaccurate. The FDA had estimated only a 0.088 percentage point reduction in smoking rates after graphic warning labels were mandated in Canada.

Jidong Huang, research specialist at UIC's Institute for Health Research and Policy and lead author of the new study, said when he and his collaborators corrected the FDA's methodological flaws and took into account the purchase prices paid by smokers, they found that graphic warning labels reduce cigarette-smoking prevalence at much higher rates.

Graphic warning labels on cigarette packages have been implemented in more than 40 countries, but not in the U.S.

In 2009, the Family Smoking Prevention and Tobacco Control Act gave the FDA authority to regulate the manufacture, distribution and marketing of tobacco products, including requiring prominent warning labels for cigarettes and smokeless tobacco products. However, the tobacco industry challenged the FDA's requirement for graphic warning labels, and a U.S. Court of Appeals ruled that the federal agency lacked evidence that graphic warning images would reduce the number of Americans who smoke. Studies had shown that such labels increase knowledge of the harmful effects of tobacco products, motivate smokers to attempt quitting, and decrease relapse rates among smokers who have quit, but not whether they reduce overall smoking rates.

The UIC and University of Waterloo researchers hope the new study will provide support for a revised FDA proposal to require graphic warnings.

The FDA should "adopt a standard methodology in doing their regulatory impact analysis that is statistically sound and validated by social scientists," said Huang. The "very rudimentary analysis" methods currently used by the FDA will cause problems in future proposals and regulations for new and emerging tobacco products, he said.

Geoffrey Fong, professor of psychology at the University of Waterloo, said the new study "adds to the strong and growing number of studies showing the powerful positive impact of graphic warnings on reducing smoking rates."

Fong and Frank Chaloupka, distinguished professor of economics and director of the Health Policy Center at UIC's Institute for Health Research and Policy, are co-investigators.


Contact: Sherri McGinnis Gonzalez
University of Illinois at Chicago

Related medicine news :

1. Study examines medicare use for Mohs micrographic surgery and surgical excision for skin cancer
2. Cancer in the elderly: Research fails to keep up with demographic change
3. Graphic warning labels improve smokers recall of warning and health risks related to smoking
4. Graphic Cig Pack Labels Make Smokers Think, Study Finds
5. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
6. Revised geographic adjustments could improve accuracy of Medicare payments, will not solve access, quality problems
7. Photographic cholesterol test
8. U.S. Appeals Court Backs Ruling Against Graphic Images on Cigarette Packs
9. WeightWise Infographic Spotlights Twinkies Ingredients’ Non-Food Uses
10. Get New Patients, INC Releases New Infographic titled 'Are Negative Reviews Killing Your Medical Practice?"
11. Graphic warnings on cigarettes effective across demographic groups
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: